Regulations.gov document
Armenpharm, Ltd.; Suspension of Approval of an Abbreviated New Drug Application for…
Notice · FDA-2011-P-0081 · posted Sep 21, 2016
Key facts
| Document ID | FDA-2011-P-0081-0021 |
|---|---|
| Title | Armenpharm, Ltd.; Suspension of Approval of an Abbreviated New Drug Application for Chloramphenicol Capsules, 250 Milligrams; Determination That CHLOROMYCETIN (Chloramphenicol) Capsules, 50 Milligrams and 100 Milligrams, and Three Other Products Were Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2011-P-0081 |
| Posted | Sep 21, 2016 |
| Federal Register citation | 81 FR 64914 |
| FR document number | 2016-22660 |
| Comment period opens | Sep 21, 2016 |
| Effective date | Sep 21, 2016 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: